Literature DB >> 9216653

5-FU-induced apoptosis correlates with efficacy against human gastric and colon cancer xenografts in nude mice.

T Inada1, A Ichikawa, T Kubota, Y Ogata, A R Moossa, R M Hoffman.   

Abstract

Apoptosis may be an important mechanism by which cancer cells are killed by certain agents. It is reported here that apoptosis is a key event in the killing of human tumor cells by 5-fluorouracil (5-FU) in vivo. Apoptosis induced by 5-FU was determined using two human gastrointestinal tumor xenografts serially transplanted into nude mice: a gastric carcinoma (SC-1-NU) highly sensitive to 5-FU and a colon carcinoma (Co-4) less sensitive to 5-FU. Apoptosis was assayed using the terminal deoxynucleotidyl transferase (TdT)-mediated deoxyuridine triphosphate (dUTP)-biotin nick end labeling method in paraffin-embedded tissue sections, and by flow-cytometric analysis. Apoptosis-positive cells increased gradually during treatment. 24 hours after the initiation of 5-FU treatment a maximum, of 15.4% of the Co-4 cells were apoptotic. 48 hours after the initiation of 5-FU treatment, apoptosis was found in 34% of the tumor cells in the SC-1-NU strain. Flow-cytometry demonstrated the increase of S-phase fractions in both strains after the administration of 5-FU, and this coincided with the appearance of apoptotic-positive cells. Although the intrinsic. TS activities of two strains differed, TS activities were markedly suppressed in both strains immediately after the administration of 5-FU. Concentration of 5-FU in RNA (F-RNA) increased gradually in both strains, reaching a maximum 24 hours after the administration of 5-FU. These results suggest that apoptosis and inhibition of DNA synthesis induced by 5-FU are closely associated with its antitumor effect.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9216653

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  8 in total

1.  Effect of preoperative regional artery chemotherapy on proliferation and apoptosis of gastric carcinoma cells.

Authors:  Hou-Quan Tao; Shou-Chun Zou
Journal:  World J Gastroenterol       Date:  2002-06       Impact factor: 5.742

2.  The antitumor effect of mesenchymal stem cells transduced with a lentiviral vector expressing cytosine deaminase in a rat glioma model.

Authors:  Song Fei; Xing Qi; Song Kedong; Ji Guangchun; Liu Jian; Qin Wei
Journal:  J Cancer Res Clin Oncol       Date:  2011-12-04       Impact factor: 4.553

Review 3.  Dark Agouti rat model of chemotherapy-induced mucositis: establishment and current state of the art.

Authors:  Barbara Vanhoecke; Emma Bateman; Bronwen Mayo; Eline Vanlancker; Andrea Stringer; Daniel Thorpe; Dorothy Keefe
Journal:  Exp Biol Med (Maywood)       Date:  2015-05-12

Review 4.  Orthotopic metastatic mouse models for anticancer drug discovery and evaluation: a bridge to the clinic.

Authors:  R M Hoffman
Journal:  Invest New Drugs       Date:  1999       Impact factor: 3.850

5.  Intravenous administration of retroviral replicating vector, Toca 511, demonstrates therapeutic efficacy in orthotopic immune-competent mouse glioma model.

Authors:  Tiffany T Huang; Shraddha Parab; Ryan Burnett; Oscar Diago; Derek Ostertag; Florence M Hofman; Fernando Lopez Espinoza; Bryan Martin; Carlos E Ibañez; Noriyuki Kasahara; Harry E Gruber; Daniel Pertschuk; Douglas J Jolly; Joan M Robbins
Journal:  Hum Gene Ther       Date:  2015-01-19       Impact factor: 5.695

6.  Synergy of Irofulven in combination with various anti-metabolites, enzyme inhibitors, and miscellaneous agents in MV522 lung carcinoma cells: marked interaction with gemcitabine and 5-fluorouracil.

Authors:  Michael J Kelner; Trevor C McMorris; Rafael J Rojas; Leita A Estes; Pharnuk Suthipinijtham
Journal:  Invest New Drugs       Date:  2008-01-29       Impact factor: 3.850

7.  Dihydropyrimidine dehydrogenase and messenger RNA levels in gastric cancer: possible predictor for sensitivity to 5-fluorouracil.

Authors:  Y Ishikawa; T Kubota; Y Otani; M Watanabe; T Teramoto; K Kumai; T Takechi; H Okabe; M Fukushima; M Kitajima
Journal:  Jpn J Cancer Res       Date:  2000-01

8.  Sorting nexin-1 is a candidate tumor suppressor and potential prognostic marker in gastric cancer.

Authors:  Xiao-Yong Zhan; Yaqiong Zhang; Ertao Zhai; Qing-Yi Zhu; Yulong He
Journal:  PeerJ       Date:  2018-05-29       Impact factor: 2.984

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.